The Historic M&A Slowdown
Global Mergers and Acquisitions Drop by 50%
During the second quarter of 2020, which ended Tuesday, mergers and acquisitions declined significantly. Globally, companies only made $485 billion worth of deals. Over the course of the same period last year, nearly $1 trillion worth of mergers and acquisitions took place—meaning there was a decline of almost 50%. In the US, the year-over-year decline was nearly 90%.
With the economy reeling due to the spread of coronavirus, there was far less liquidity in the financial markets. Rather than expanding through mergers and acquisitions, companies had to focus on saving their existing businesses and finding back-up credit lines instead.
Private Equity Companies Stayed Active
Private equity firms managed to make more deals last quarter than other companies. The sector accounted for 16% of M&A activity, which is the highest percentage of deals PE firms have been responsible for since 2007.
When the quarter began, the private equity industry had $2.5 trillion in capital from investors to spend. Some PE firms look back on the 2008 financial crash with regrets about not investing more boldly when companies were discounted. As a result, some PE companies are hunting for deals more aggressively now. For example, KKR (KKR) recently bought Viridor, a UK-based recycling company, for $5.23 billion. KKR also partnered with Providence Equity Partners and Cinven to acquire Masmovil, a Spanish telecom operator, for $5.6 billion.
Looking Ahead
Companies face an uncertain future with questions looming about a second wave of COVID-19 infections and the US presidential election. However, most analysts are optimistic that, despite the many unknowns, mergers and acquisitions will come trickling back.
The food delivery industry is already seeing activity and could lead the way for mergers and acquisitions in other sectors. In June, Netherlands-based JustEatTakeaway.com (TKAYY) bought Grubhub (GRUB) for $7.3 billion. Currently, Uber (UBER) is in talks about acquiring Postmates. Analysts also expect to see mergers in the biotechnology and pharmaceutical industries soon.
Despite uncertain conditions and a historically slow second quarter, companies may be willing to take more risks this quarter, which could bring back M&A activity.
Please understand that this information provided is general in nature and shouldn’t be construed as a recommendation or solicitation of any products offered by SoFi’s affiliates and subsidiaries. In addition, this information is by no means meant to provide investment or financial advice, nor is it intended to serve as the basis for any investment decision or recommendation to buy or sell any asset. Keep in mind that investing involves risk, and past performance of an asset never guarantees future results or returns. It’s important for investors to consider their specific financial needs, goals, and risk profile before making an investment decision.
The information and analysis provided through hyperlinks to third party websites, while believed to be accurate, cannot be guaranteed by SoFi. These links are provided for informational purposes and should not be viewed as an endorsement. No brands or products mentioned are affiliated with SoFi, nor do they endorse or sponsor this content.
Communication of SoFi Wealth LLC an SEC Registered Investment Advisor
SoFi isn’t recommending and is not affiliated with the brands or companies displayed. Brands displayed neither endorse or sponsor this article. Third party trademarks and service marks referenced are property of their respective owners.
SOSS070201